Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 1 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Glioma 1

Interventions

Magnetic Resonance Spectroscopy 16 Blood Specimen Collection 8 Temozolomide 5 Magnetic Resonance Imaging 5 Bevacizumab 4 Yoga 3 Radiotherapy, Intensity-Modulated 3 Biopsy 3 Transcranial Magnetic Stimulation 2 Surveys and Questionnaires 2 Restraint, Physical 2 Radiosurgery 2 Radiation 2 Psychosocial Intervention 2 Proton Therapy 2 Physical Therapy Modalities 2 Palliative Care 2 Mind-Body Therapies 2 Mental Status and Dementia Tests 2 Heart Rate 2 Gadolinium DTPA 2 Exercise 2 Elasticity Imaging Techniques 2 Drug Therapy 2 Diffusion Tensor Imaging 2 Congresses as Topic 2 Aminolevulinic Acid 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 vandetanib 1 poly ICLC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioma × poly ICLC × Clear all

NCT05557240 2022-10-12

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Shanghai 10th People's Hospital

Phase NA Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡